Denise Pollard-Knight
Affiliations
- Chief Executive Officer at Mereo Biopharma Group Plc (MREO), 2025-01-28
- at Elanco Animal Health Inc (ELAN), 2024-12-03
- Director at Oncomed Pharmaceuticals Inc (OMED), 2018-06-25
- Large Shareholder, Director at Albireo Pharma Inc. (ALBO), 2017-06-20
- Director at Idenix Pharmaceuticals Inc (IDIX), 2014-08-05
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| OMED | $17.00 | 58,824 | $1,000,008.00 | 2,122,807 | 2013-07-23 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| MREO | $4.22 | 60,046 | $253,454.17 | 808,921 | 2024-09-13 | Filing |
| MREO | $4.47 | 28,611 | $127,968.42 | 868,967 | 2024-09-12 | Filing |
| MREO | $3.39 | 92,273 | $313,100.74 | 709,518 | 2024-06-26 | Filing |
| MREO | $3.69 | 40,712 | $150,386.06 | 801,791 | 2024-06-25 | Filing |
| OMED | $21.66 | 3,799 | $82,299.64 | 1,943,509 | 2014-12-31 | Filing |